It is postulated that serum Krebs von den Lungen‐6 (KL‐6), a mucin‐like protein produced by Type 2 alveolar lung cells, may become a marker of JDM‐ILD, as its level correlates with the severity and extent of lung involvement on HRCT [17]. The gene discussed is MUC1; the disease is interstitial lung disease.